Get the latest OSIR - Osiris Therapeutics Incorporated stock market performance data and financial news.
Get the latest OSIR - Osiris Therapeutics Incorporated together with stock market performance data and financial news.
Read Jim Cramer's take on Osiris Therapeutics Incorporated (OSIR) and get his latest thoughts on the company?s performance and outlook
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Osiris Therapeutics' shoddy work and shortcuts in its previous clinical trials for stem cell drug Prochymal led to the failure of two late-stage trials.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10595563/1/osiris-drugs-failure-was-easy-to-envision.html
A press release regarding the end of a trial of stem-cell drug Prochymal highlights all that's wrong with this company.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10478605/1/osiris-up-to-its-old-tricks-again.html
Simcere is down 24%.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10446272/1/health-winners-losers-kendle.html
Jim Bianco unloads 30% of holdings days after investor meeting.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10597856/1/cell-therapeutics-ceo-sells-stock-biobuzz.html
Osiris is up 9.5%.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10446525/1/health-winners-losers-amgen.html
Negative results announced from two phase III studies in graft-versus-host-disease. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10595380/1/osiris-stem-cell-drug-fails-biobuzz.html
Connect with TheStreet